Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

What's Causing Recurrent Syncope in This Young Man?

Clinicians may see more cases like this in the future

Lionel Richie's Afib Ablation Draws Attention to the Heart Rhythm Disorder

— Recent advances in ablation techniques have introduced new technologies

Stroke-Heart Syndrome: The 'Perfect Storm'

Clinicians describe significant diagnostic and treatment challenges for a young patient

STEMI-Related Spontaneous Coronary Artery Dissection in a Young Woman

Initial thrombolysis implicated in patient's sudden cardiac arrest, managed with emergency PCI

USPSTF's New Cardiologists; Wrist Nerve Stimulator for Afib; Doc Impaled by Tree

— Recent developments of interest in cardiovascular medicine

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

— Rival to the Agent DCB had been shown noninferior to DES

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

Clinicians may see more cases like this in the future

— Recent advances in ablation techniques have introduced new technologies

Clinicians describe significant diagnostic and treatment challenges for a young patient

Initial thrombolysis implicated in patient's sudden cardiac arrest, managed with emergency PCI

— Recent developments of interest in cardiovascular medicine

— Rival to the Agent DCB had been shown noninferior to DES

News All Time

Rush to PCSK9 Inhibitor Pretreatment Disappoints in Acute MI Trial

Quick lipid lowering did not translate to clinical benefit at 1 year

Factor XIa Inhibitor Shows No Benefit After Acute Coronary Syndrome

Milvexian was safe, but not effective in preventing events in high-risk patients

Tricuspid Valve Repair Finally Proven to Keep HF Events At Bay

Landmark TRIC-I-HF trial links repair to benefits in hard outcomes

Trial Delivers Good News for Pulmonary Embolism Treatment

Adding catheter-directed thrombolysis to standard care cut risk for death and other bad outcomes

No Benefit of Routine CT Angiography After Ruling Out a Heart Attack

Also, researchers looked at two pathways to manage high-sensitivity cardiac troponin measurements

Trial Tentatively Backs DOACs After TAVR

HALT reduced without increase in safety events compared with aspirin

GLP-1 Studies Suggest Benefits Extend to Infectious Diseases

Another positive side effect of blockbuster diabetes, weight-loss drugs?

FDA Adds Boxed Warning to Iron Replacement Injection

Label change for ferric carboxymaltose warns of risk for symptomatic hypophosphatemia

Plozasiran Notches Big Wins in Severe Hypertriglyceridemia

Drug has "very good chance of being game-changing in the clinic," says researcher

New MI Definition; Lipid-Lowering Advances; Former ESC Prez's Misconduct?

Recent developments of interest in cardiovascular medicine

Infective Endocarditis Trial Backs Less Intense Antibiotic Approach

Patients randomized to tailored approach needed 15 fewer days of antibiotics in POET II

People With Unexplained Fainting Finally Get Some Answers With Take-Home Device

ASPIRED trial tested a strategy of extended ECG monitoring starting in the emergency department

Sad Trial Names: Social Media Thinks Cardiology Is Going Through It

Two trials from the same research group sound like vulnerable relationship status updates

Denervation Shows Potential in Heart Failure-Related Pulmonary Hypertension

Results of open-label trial promising but need further confirmation, says expert

Fatty Food, Prostate Cancer, and Death -- A New Study Weighs In

Higher saturated fat intake tied to greater mortality risk, likely due to cardiovascular disease

Nurse Found Dead; New Moms Stirred by Clancy Trial; Tim Curry's Cause of Death

Health news and commentary gathered by MedPage Today staff

Recommended News For You

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

Researchers discover that children who survive cancer have socioeconomic challenges.

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

Study finds primary-care doctors often overlook prostate cancer risk in Black men

AVD Chemo Regimen Shows Promise in Older Patients With HL

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

Recommended Articles For You

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress 

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How artificial intelligence could significantly improve the prognosis for cancer patients.

2.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

3.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

4.

How a California Oncologist Making $850k Spends Money

5.

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

1.

What You Need to Know About the Early Warning Signs of Colon Cancer 

2.

Ferroptosis-Modulating Therapeutics in Precision Oncology

3.

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes

4.

Uncovering the Mysteries of the RDW Blood Test

5.

Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Understanding the Importance of Follow-Up After Cancer Treatment

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot